Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase inhibitors help treat prostate enlargement and hair loss but may cause side effects, requiring careful use.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

Higher doses of 5α-reductase inhibitors may lower mortality risk, but low doses increase it.

Higher doses of 5α-reductase inhibitors reduce mortality risk, while lower doses increase suicide risk.

Drugs for prostate enlargement and hair loss were not linked to increased risk of depression or suicide.

New treatments for male hair loss are being explored to improve effectiveness and reduce side effects.

Finasteride 5mg daily is the most effective for female pattern hair loss, with higher doses of treatments generally more effective.

5α-reductase inhibitors do not improve survival in oesophageal and gastric cancer patients.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

A man's low testosterone and related symptoms improved after he stopped taking hair loss drugs.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

5α-Reductase inhibitors may increase depression risk but not dementia or suicide.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

5α-reductase inhibitors may lower the risk of death from bladder cancer.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Personalized treatment is crucial for effectively managing benign prostatic hyperplasia (BPH).

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

Most dermatologists think post-finasteride syndrome is rare, possibly psychiatric, and needs more research.

Finasteride improves prostate cancer prediction by adjusting kallikrein marker levels.

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

5-ARI therapy may help prevent prostate cancer progression.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.